Start here
Brimonidine takes the red out of a rosacea face within an hour, then wears off by evening. In a minority of people the redness returns worse than it started, and that rebound is the main reason people stop. So test it on one small area for several days first, and use far less than you think — a pea-sized amount for the whole face, not per cheek. It treats color only, not bumps.
— Dr. Schwarz, Board Certified Dermatologist
Key Facts
−
| Also called | Mirvaso, brimonidine tartrate 0.33% gel |
| Drug class | Alpha-2 adrenergic agonist, a blood vessel constrictor |
| Applied as | 0.33% gel |
| Typical course | Daily or as needed, for appearance |
| Time to work | About 30 minutes, at its strongest 3 to 6 hours in |
| Prescription only | Yes |
What It Is
−
Brimonidine gel is a prescription gel approved in 2013 for the persistent facial redness of rosacea in adults. The same molecule is used in glaucoma eye drops; here it is formulated for the small blood vessels in facial skin. It treats appearance, not disease — no change to the course of rosacea, no effect on inflammation, nothing for papules and pustules. It makes skin look less red for part of a day.
How It Works
−
The fixed pink of rosacea comes largely from small facial blood vessels that stay wider than they should. Brimonidine is an alpha-2 adrenergic agonist: it makes the muscle in those vessel walls contract, so less blood sits near the surface and the skin reads as less red. Redness starts to fade about half an hour after applying, is least three to six hours in, and is generally gone by twelve.
In a minority of people the vessels do not simply return to where they started. As the gel wears off, or after several days of daily use, the face can become redder than baseline, sometimes with burning and a feeling of heat. This is rebound erythema, or paradoxical erythema.
Why it happens is not settled. It is not an allergy and not damage, and it settles over days to a couple of weeks after stopping. But it is common enough to plan for rather than discover.
Here is where Brimonidine (Mirvaso) acts in the skin.
About Brimonidine (Mirvaso)
Skin basics
Brimonidine (Mirvaso) tightens the widened vessels that make the skin look red. The colour fades for several hours and then returns: it treats how the skin looks that day and does nothing to the vessels themselves. Lasts several hours. Some people flush worse as it wears off.
Brimonidine crosses the barrier and reaches the vessels in the dermis. Enough gets in that stopping suddenly can leave the skin redder than it started.
The outer film of dead cells and oil. It holds water in and keeps irritants out, and it is thinner than a sheet of paper. Almost every dry, itchy, stinging skin problem starts here.
The outer layer, and the only one anything in a jar reaches. It renews itself constantly: a cell made at the bottom takes about a month to reach the surface and flake off. Most of what a skincare product does, it does here.
The living layer underneath, holding the blood vessels, the nerves and the collagen. It is where lasting change happens and it is hard to reach: most of what is sold for the skin never gets this far.
What It Treats
−

Not the Best For
−

Forms
−
One strength, one texture.
0.33% gel:
Brimonidine eye drops:
Strengths
−
One strength only. Using more does not work better — it makes burning and rebound more likely.
Basics
−
Sample Routine
−
Here is where Brimonidine (Mirvaso) sits in a day, and what goes around it. Pick what you are treating and what your skin is like, and the rest of the routine changes to suit.
What to Expect
−
What to Avoid
−
- More than a pea-sized amount The most common mistake, linked to burning and rebound.
- Applying it twice in a day Once daily is the maximum. Topping up as it wears off makes rebound more likely.
- Broken, raw or sunburned skin More is absorbed and it stings.
- The eyes and eyelids Keep it away, and rinse with water if it gets in.
- Leaving it where a child can reach it Swallowing it can make a small child seriously unwell. Wash your hands after use.
- Whole-face use on day one A small test area tells you what you need to know.
Monitoring
−
No blood tests for ordinary use. What is monitored is what you can see: does the redness fade, does it come back worse, does burning settle.
A small amount is absorbed, so the gel carries the theoretical body-wide effects of its class — low blood pressure, a slow heart rate, drowsiness, dizziness. These are rare on intact skin, but they are why heart disease, low blood pressure, circulatory problems or an existing brimonidine eye drop should be raised before you start.
Review a few weeks in — is this worth continuing.
If You Stop
−
Stop any time. There is no taper. If you have been using it without trouble, the redness returns to its usual level within a day. It was not treating rosacea, so nothing relapses. If you are stopping because of rebound, the redness settles back to baseline over days to a couple of weeks, and it can look worse before it looks normal. Cool compresses, a plain moisturizer and pausing other actives is the usual advice meanwhile. Repeated rebound is a reason to switch rather than persist.
Cost
−
Brand priced for most of its life, and often not covered, because insurers treat facial redness as cosmetic. Generic brimonidine gel has appeared in some markets, bringing the price down unevenly. A tube lasts a long time if you stick to the pea-sized rule. If cost is the barrier, the honest question is whether a treatment lasting twelve hours that does not change the disease is where the budget should go, or whether laser or light treatment is the better buy.
Ask Your Doctor
−
How It Compares
−
Myths
+
- "It cures rosacea." It changes color for part of a day. The condition underneath is unchanged.
- "It treats the pimples too." Nothing for papules and pustules. Those need ivermectin, azelaic acid, metronidazole or an oral treatment.
- "Rebound redness means my skin is damaged." Blood vessels behaving differently, not an injury. It settles after stopping.
- "More gel means less redness." The opposite. Over-application is most linked to burning and rebound.
- "It is the same thing as the eye drops that take redness out of eyes." Brimonidine is in glaucoma drops, but the concentrations and purposes differ.
- "If it worked once it will keep working better." No cumulative benefit. Every application starts from the same place.
Questions Patients Ask
+
What is rebound redness, and how likely is it?
Redness that comes back worse than it started, as the gel wears off or after several days of use, sometimes with burning. A minority of users, but the main reason people stop. It settles within a couple of weeks of stopping.
Can I make rebound less likely?
Use less than you think — a pea-sized amount for the whole face, once a day at most — and test one small area for several days first. Over-application is the pattern most linked to trouble.
Will it help my rosacea bumps?
No. It is a blood vessel treatment. Bumps and pustules need a separate medicine, and the two are often prescribed together.
How long does one application last?
It begins around thirty minutes, peaks at three to six hours, and is gone by twelve. It does not accumulate, so daily use is not needed if you want it for occasions.
Can I wear makeup over it?
Yes, once it has dried.
Does it work on broken capillaries?
Not really. Those are visible individual vessels; they need laser or light. Brimonidine pales the background around them, which can make them look less obvious.
References
+
- Clanner-Engelshofen BM, Bernhard D, Dargatz S, et al. S2k guideline: Rosacea. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 2022. — Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2022
- Gao X, Xiang W. Efficacy of Widely Used Topical Drugs for Rosacea: A Systematic Review and Meta-Analysis. Actas dermo-sifiliograficas. 2025. — Actas dermo-sifiliograficas, 2025
- van Zuuren EJ, Fedorowicz Z, Tan J, et al. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments. The British journal of dermatology. 2019. — The British journal of dermatology, 2019
- van Zuuren EJ, Fedorowicz Z, Carter B, et al. Interventions for rosacea. The Cochrane database of systematic reviews. 2015. — The Cochrane database of systematic reviews, 2015
- Loon SC, Liew G, Fung A, et al. Meta-analysis of randomized controlled trials comparing timolol with brimonidine in the treatment of glaucoma. Clinical & experimental ophthalmology. 2008. — Clinical & experimental ophthalmology, 2008
